Biotech Equipment Could Be $144B Market by 2030: What It Means for Pharma R&D

The global biotechnology equipment market is set for robust expansion, projected to reach $143.9 billion by 2030, findings from a recent BCC Research report have indicated (1,2). This figure reflects a compound annual growth rate of 8.6% from the 2025 estimated value of $95.1 billion. This significant market surge is crucial for the pharmaceutical sector, as drug discovery, development, and manufacturing operations rely heavily on advanced analytical and processing technologies.

The expansion is propelled by several macro factors directly affecting pharma R&D budgets, including rising government and private investment in biotech research (1). Additionally, the industry's shift toward customized therapies, such as personalized medicine, necessitates the acquisition of specialized tools for gene sequencing and biomarker analysis. This push for tailored treatments stands to fundamentally change the required technology footprint in preclinical and clinical stages.

Given that, as the report states, pharmaceutical companies account for the majority of biotech equipment purchases, stakeholders in drug discovery, development, and manufacturing must be prepared to integrate these essential technological advancements to maintain competitiveness (2). Key findings from this market forecast include the following:

R&D investment drives equipment adoption

Increased funding from governments and institutions accelerates biotech research, directly fueling demand for sophisticated laboratory tools essential for experimentation and innovation in early-stage discovery.

Automation and AI redefine processes

The integration of cutting-edge technologies like automation, artificial intelligence, and robotics into biotech instruments is making drug discovery and development processes faster, more accurate, and highly scalable. This necessitates capital upgrades to leverage efficient workflow management.

Precision medicine mandates specialized tools

The growing focus on developing treatments tailored to individual genetics increases the need for specialized equipment supporting gene sequencing, sophisticated diagnostics, and thorough biomarker analysis across development pipelines.

Biologics production requires high-end machinery

The rapid expansion of biopharmaceutical production, particularly in vaccines and cell therapies, demands high-performance equipment for efficient production, rigorous purification, and precise quality control in manufacturing facilities.

Analytical instruments lead market adoption

Analytical instruments are forecasted to dominate the overall biotechnology equipment market, underlining the critical importance of robust measurement and testing capabilities throughout the entire drug lifecycle.

References

1. BCC Publishing, Global Biotechnology Equipment Market; BCC Research, August 2025.
2. BCC Research LLC. Biotech Equipment Market Projected to Reach $143.9 Billion Globally by 2030. Press Release. Oct. 15, 2025.